These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29109936)

  • 1. A study of harmful drug-drug interactions due to polypharmacy in hospitalized patients in Goa Medical College.
    Khandeparkar A; Rataboli PV
    Perspect Clin Res; 2017; 8(4):180-186. PubMed ID: 29109936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and associated factors of polypharmacy in older patients in primary care: a northern Italian cross-sectional study.
    Piccoliori G; Mahlknecht A; Sandri M; Valentini M; Vögele A; Schmid S; Deflorian F; Engl A; Sönnichsen A; Wiedermann C
    BMC Geriatr; 2021 Mar; 21(1):197. PubMed ID: 33743582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
    Lin CF; Wang CY; Bai CH
    Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
    Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
    J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
    Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO
    Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
    Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
    Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
    Hong S; Lee JH; Chun EK; Kim KI; Kim JW; Kim SH; Lee YG; Hwang IG; Kim JY; Koh SJ; Ko YH; Shin SH; Woo IS; Kim TY; Baek JY; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Ryoo HM; Kim JH
    Oncologist; 2020 Mar; 25(3):e502-e511. PubMed ID: 32162799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software.
    Zakrzewski-Jakubiak H; Doan J; Lamoureux P; Singh D; Turgeon J; Tannenbaum C
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):461-70. PubMed ID: 22019006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prevalence of Polypharmacy and Potential Drug-Drug Interactions among Iranian Cancer Patients: Which Patients were at Risk?
    Bazrafshani MS; Pardakhty A; Kalantari Khandani B; Nasiri N; Moghaderi M; Bazrafshani A; Mehmandoost S; Beigzadeh A; Sharifi H
    Cancer Invest; 2022 May; 40(5):457-472. PubMed ID: 35099344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy in patients with advanced cancer and pain: a European cross-sectional study of 2282 patients.
    Kotlinska-Lemieszek A; Paulsen O; Kaasa S; Klepstad P
    J Pain Symptom Manage; 2014 Dec; 48(6):1145-59. PubMed ID: 24780183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States.
    Sheikh-Taha M; Asmar M
    BMC Geriatr; 2021 Apr; 21(1):233. PubMed ID: 33827442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential drug-drug interactions among prescriptionsfor elderly patients in primary health care.
    Gören Z; J Demirkapu M; Akpinar Acet G; Çali S; Gülçebi Idriz Oğlu M
    Turk J Med Sci; 2017 Feb; 47(1):47-54. PubMed ID: 28263519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the French healthcare insurance database to estimate the prevalence of exposure to potential drug-drug interactions.
    Souty C; Launay T; Steichen O; Conte C; Turbelin C; Sarazin M; Vilcu AM; Rossignol L; Blanchon T; Lapeyre-Mestre M; Hanslik T
    Eur J Clin Pharmacol; 2020 Dec; 76(12):1675-1682. PubMed ID: 32632714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy, potentially serious clinically relevant drug-drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life.
    Al-Musawe L; Torre C; Guerreiro JP; Rodrigues AT; Raposo JF; Mota-Filipe H; Martins AP
    Pharmacol Res Perspect; 2020 Aug; 8(4):e00621. PubMed ID: 32618136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Polypharmacy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Older Adults.
    Sugidono M; Lo M; Young R; Rosario K; Jung Y; Huang CY; Sheng Y; Huang LW; Olin RL
    Transplant Cell Ther; 2021 Apr; 27(4):344.e1-344.e5. PubMed ID: 33836888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management.
    Zhou YT; Yu LS; Zeng S; Huang YW; Xu HM; Zhou Q
    Ther Clin Risk Manag; 2014; 10():17-26. PubMed ID: 24379677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance.
    Tulner LR; Frankfort SV; Gijsen GJ; van Campen JP; Koks CH; Beijnen JH
    Drugs Aging; 2008; 25(4):343-55. PubMed ID: 18361544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey on Polypharmacy and Drug-Drug Interactions Among Elderly People with Cardiovascular Diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia.
    Assefa YA; Kedir A; Kahaliw W
    Integr Pharm Res Pract; 2020; 9():1-9. PubMed ID: 32021833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentially inappropriate prescribing and drug-drug interactions among elderly Chinese nursing home residents in Macao.
    Lao CK; Ho SC; Chan KK; Tou CF; Tong HH; Chan A
    Int J Clin Pharm; 2013 Oct; 35(5):805-12. PubMed ID: 23812679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.